SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-459650
Filing Date
2012-11-08
Accepted
2012-11-08 12:08:43
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d404053d10q.htm 10-Q 424828
2 SECTION 302 CEO CERTIFICATION d404053dex311.htm EX-31.1 6044
3 SECTION 302 CFO CERTIFICATION d404053dex312.htm EX-31.2 6033
4 SECTION 906 CEO AND CFO CERTIFICATION d404053dex321.htm EX-32.1 7095
  Complete submission text file 0001193125-12-459650.txt   4165392

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgen-20120930.xml EX-101.INS 604458
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20120930.xsd EX-101.SCH 42499
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20120930_cal.xml EX-101.CAL 57525
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20120930_def.xml EX-101.DEF 244993
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20120930_lab.xml EX-101.LAB 348133
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20120930_pre.xml EX-101.PRE 287311
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 121189087
SIC: 2836 Biological Products, (No Diagnostic Substances)